Sun, May 26, 2013, 3:38 AM EDT - U.S. Markets closed
The FDA approval has been insured after this company adds 200 more patient for the final ph3, big heads in the field should be very interested in partnering with SNSS since there is no competition for tis drug.
Sentiment: Strong Buy
If it happens, pps will pop to $30